β¨ Fisheries and Health Notices
24 AUGUST NEW ZEALAND GAZETTE 2433
- Exemption to quota aggregation limitβ(1) As from the date that this notice comes into effect, consent is given for Burkhart Fisheries to hold (whether by allocation or by taking on transfer or lease or by any combination of those means) no more than 16.38% of the total of transferable term quota for CRA 5.
Dated at Wellington this 21st day of August 1995.
D. L. KIDD, Minister of Fisheries.
- S.R. 1986/267
β S.R. 1990/214
go5620
Health
Medicines Act 1981
Consent to the Distribution of New Related Product
Pursuant to section 96 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Cetylpyridinium chloride 1.5 mg | Lozenge (mint leaf flavour) | Tokiwa Chemical Industries Limited, Shirakashi, Ueno-Shi, Japan | Actifed Antiseptic Lozenge |
| Cetylpyridinium chloride 1.5 mg | Lozenge (blue ice flavour) | Tokiwa Chemical Industries Limited, Shirakashi, Ueno-Shi, Japan | Actifed Antiseptic Lozenge |
| Cetylpyridinium chloride 1.5 mg | Lozenge (lemon dew flavour) | Tokiwa Chemical Industries Limited, Shirakashi, Ueno-Shi, Japan | Actifed Antiseptic Lozenge |
Dated this 17th day of August 1995.
KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go5546
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Sodium hyaluronate 3% in 0.65 mL | Ophthalmic solution (pre-filled syringe) | Chesapeake Biological Laboratories; Baltimore, United States of America | AMO Vitrax Solution |
| Diazepam 5 mg per mL in 2mL | Solution for injection | Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia | Diazepam Injection |
| Erythromycin ethylsuccinate equivalent to 400 mg erythromycin | Tablet | Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia | E-Mycin |
| Erythromycin ethylsuccinate equivalent to 200 mg erythromycin | Granules for suspension (oral) | Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia | E-Mycin 200 |
| Erythromycin ethylsuccinate equivalent to 400 mg erythromycin | Granules for suspension (oral) | Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia | E-Mycin 400 |
| Polyethylene glycol 3500 180 mg in 200 mg (6% w/w per L) | Powder for reconstitution (oral) | DFC Thompson Pty Limited, Hornsby, New South Wales, Australia | Glycoprep |
| Cladirbine 1 mg/mL in 10 mL | Solution for intravenous infusion (vial) | Iolab, Division of Johnson & Johnson Pharm Co (PR) Inc., San German, Puerto Rico and Janssen Pharmaceutica Inc, Fort Washington, Philadelphia, United States of America | Leustatin Injection |
| Selegiline hydrochloride 5 mg, 10 mg | Tablets | Douglas Pharmaceuticals Limited, Mount Roskill, Auckland | Oravant |
| Quinine dihydrochloride 600 mg in 10 mL | Solution for infusion (ampoule) | Biomed Laboratories Limited, Point Chevalier, Auckland | Quinine Dihydrochloride Injection |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1995, No 85
NZLII —
NZ Gazette 1995, No 85
β¨ LLM interpretation of page content
πΎ
Fisheries (Quota Aggregation Limit Exemption) Notice (No. 2) 1995
(continued from previous page)
πΎ Primary Industries & Resources21 August 1995
Fisheries Act 1983, Quota Aggregation Limit Exemption, Burkhart Fisheries
- Burkhart, Granted exemption to quota aggregation limit
- D. L. Kidd, Minister of Fisheries
π₯ Consent to Distribution of New Related Product
π₯ Health & Social Welfare17 August 1995
Medicines Act 1981, New related product, Cetylpyridinium chloride, Actifed Antiseptic Lozenge
- Karen O. Poutasi, Director-General of Health
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare17 August 1995
Medicines Act 1981, New medicines, Sodium hyaluronate, Diazepam, Erythromycin, Polyethylene glycol, Cladirbine, Selegiline hydrochloride, Quinine dihydrochloride
- Karen O. Poutasi, Director-General of Health